Eltrombopag-associated erythromelalgia in idiopathic thrombocytopenic purpura
- PMID: 34698373
- DOI: 10.1111/bjd.20829
Eltrombopag-associated erythromelalgia in idiopathic thrombocytopenic purpura
References
-
- Kondo T, Uehara T, Ikegami A, Ikusaka M. Paroxysmal burning pain caused by erythromelalgia. Lancet 2014; 383:1692.
-
- Mørk C, Asker CL, Salerud EG, Kvernebo K. Microvascular arteriovenous shunting is a probable pathogenetic mechanism in erythromelalgia. J Invest Dermatol 2000; 114:643-6.
-
- Jha SK, Karna B, Goodman MB. Erythromelalgia. In: StatPearls. Treasure Island, FL: StatPearls Publishing, 2021. Available at: http://www.ncbi.nlm.nih.gov/books/NBK557787/ (last accessed 21 May 2021).
-
- Mann N, King T, Murphy R. Review of primary and secondary erythromelalgia. Clin Exp Dermatol 2019; 44:477-82.
-
- Revolade® (Eltrombopag). [Product information]. Amsterdam: European Medicines Agency - EPAR, 2019.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources